AJCN EB Program 2010 Early Registration
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Amundsen, A. L
Right arrow Articles by Ntanios, F. Y
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Amundsen, A. L
Right arrow Articles by Ntanios, F. Y
Agricola
Right arrow Articles by Amundsen, A. L
Right arrow Articles by Ntanios, F. Y
American Journal of Clinical Nutrition, Vol. 76, No. 2, 338-344, August 2002
© 2002 American Society for Clinical Nutrition


Original Research Communication

Plant sterol ester–enriched spread lowers plasma total and LDL cholesterol in children with familial hypercholesterolemia1,2

Ågot L Amundsen, Leiv Ose, Marit S Nenseter and Fady Y Ntanios

1 From the Lipid Clinic (ÅLA and LO) and the MSD Cardiovascular Research Center (MSN), National Hospital, Oslo, and the Unilever Health Institute, Unilever Research, Vlaardingen, Netherlands (FYN).

Background: Naturally occurring plant sterol esters (SEs) favorably affect serum cholesterol concentrations in humans and could aid in the treatment of children with familial hypercholesterolemia (FH).

Objective: We studied the effect of SE-enriched spread on serum lipids, lipoproteins, carotenoids, fat-soluble vitamins, and physiologic variables in children with FH aged 7–12 y.

Design: In a randomized, double-blind crossover study comprising two 8-wk interventions, 38 children with FH consumed 18.2 ± 1.5 g SE spread/d, corresponding to 1.60 ± 0.13 g SEs, or a control spread. Blood samples were analyzed at the start and end of each diet period.

Results: Plasma LDL-cholesterol concentrations decreased by 10.2% (P = 0.003) during the SE period compared with the control period. Total cholesterol and apolipoprotein B concentrations were reduced by 7.4% (P = 0.007 and P = 0.020, respectively) during the SE period. No changes were observed in HDL cholesterol, triacylglycerol, or apolipoprotein A-I. Serum concentration of lipid-adjusted lycopene decreased by 8.1% (P = 0.015) in the SE period, with no changes in the other carotenoids. Lipid-adjusted retinol and {alpha}-tocopherol concentrations increased by 15.6% (P < 0.001) and 7.1% (P = 0.027), respectively. There was an increase (16.8%, P = 0.04) in alanine transaminase in the SE period, but this was explained by a significantly lower starting concentration in the SE period than in the control period. The children consumed a recommended American Heart Association Step I diet during both intervention periods.

Conclusion: A daily intake of 1.6 g SEs induces an additional reduction in LDL-cholesterol concentrations in children with FH consuming a recommended diet.

Key Words: Plant sterol ester • plant sterol supplement • sitosterol ester • familial hypercholesterolemia • serum cholesterol • children • LDL cholesterol




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
P. O. Kwiterovich Jr.
Recognition and Management of Dyslipidemia in Children and Adolescents
J. Clin. Endocrinol. Metab., November 1, 2008; 93(11): 4200 - 4209.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
E. M. Haney, L. H. Huffman, C. Bougatsos, M. Freeman, R. D. Steiner, and H. D. Nelson
Screening and Treatment for Lipid Disorders in Children and Adolescents: Systematic Evidence Review for the US Preventive Services Task Force
Pediatrics, July 1, 2007; 120(1): e189 - e214.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
US Preventive Services Task Force
Screening for Lipid Disorders in Children: US Preventive Services Task Force Recommendation Statement
Pediatrics, July 1, 2007; 120(1): e215 - e219.
[Full Text] [PDF]


Home page
J. Am. Coll. Nutr.Home page
K. G. Moruisi, W. Oosthuizen, and A. M. Opperman
Phytosterols/Stanols lower cholesterol concentrations in familial hypercholesterolemic subjects: a systematic review with meta-analysis.
J. Am. Coll. Nutr., February 1, 2006; 25(1): 41 - 48.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
I. A Castro, L. P Barroso, and P. Sinnecker
Functional foods for coronary heart disease risk reduction: a meta-analysis using a multivariate approach
Am. J. Clinical Nutrition, July 1, 2005; 82(1): 32 - 40.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Hedman, T. Matikainen, A. Fohr, M. Lappi, S. Piippo, M. Nuutinen, and M. Antikainen
Efficacy and Safety of Pravastatin in Children and Adolescents with Heterozygous Familial Hypercholesterolemia: A Prospective Clinical Follow-Up Study
J. Clin. Endocrinol. Metab., April 1, 2005; 90(4): 1942 - 1952.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. A. Kreisberg and A. Oberman
Medical Management of Hyperlipidemia/Dyslipidemia
J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2445 - 2461.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by The American Society for Nutrition